Cough clinical trials at UCSF

1 in progress, 0 open to eligible people

Efficacy and Safety Study of Orvepitant for Chronic Cough in Patients With Idiopathic Pulmonary Fibrosis
Sorry, not currently recruiting here
ORV-PF-01 is a two way, placebo controlled, cross-over study, to evaluate the effect of two doses of orvepitant on cough in patients with IPF.
San Francisco, California and other locations

Last updated: July 20, 2022